RhoA is a potential candidate since it has been shown to be an upstream regulator of p38 in enhancing migration and invasion of breast cancer [11] and pancreatic carcinoma cells [32] and to be inhibited by PKA-dependent phosphorylation on serine 188 [11], [58]. This evidence concerns the gene MAPK14 and exocrine pancreatic carcinoma.